A Powerful Demonstration: MTM May Be Counterpoint To Pricing Complaints
This article was originally published in RPM Report
Executive Summary
A proposed “enhanced” model for Medication Therapy Management in Medicare Part D draws rave reviews from a House subcommittee. The prospect of using medication better to lower overall costs is a great counterpoint to headlines about excessive drug prices.
You may also be interested in...
Medication Therapy Management: The Gap Between Theory And Practice
US Medicare Payment Advisory Commission still sees promise in ‘Medication Therapy Management’ programs. But why is the value of enhanced pharmacy support for patients on complex prescription regimens so hard to prove in actual practice?
Medicare Part D ‘Enhanced’ MTM Model: Not Much To Show After Three Years?
Medication therapy management program has not produced savings in Medicare spending on medical services or a significant, consistent benefit on improving adherence or reducing hospitalizations, report finds.
Medicare Part D ‘Enhanced MTM Model’ Saves $325m In First Year
US Centers for Medicare and Medicaid Services announces first-year results from its medication therapy management model, intended to optimize prescription drug use among Medicare beneficiaries.